First assess progression accurately
It matters what has changed: individual new lesions, growth of existing tumour sites or broader progression. Imaging, clinical course and, where appropriate, repeat tissue or molecular diagnostics can influence further planning.
Subsequent lines and treatment changes
Many cancers have several lines of treatment. Depending on biomarkers and prior therapy, other systemic treatments, targeted medicines, immunotherapies, local procedures or clinical trials may be considered.
Do not stop treatment on your own
Ongoing cancer treatment should not be changed or stopped on the basis of general internet information. Benefits, side effects and alternatives need to be discussed with the treating oncology team.
Immuno-oncology options
Whether approved immunotherapies or other immunological approaches are relevant depends strongly on tumour type and biomarkers. Dendritic-cell approaches are distinct and should be assessed separately in relation to the evidence and individual situation.
Which documents are helpful?
- current and previous imaging
- histology/pathology
- treatment history with doses and dates
- molecular findings/biomarkers
- current laboratory values and medication list
Have your individual medical records reviewed
Existing reports, histology, current imaging, previous treatments and – where available – molecular findings can be brought together for structured orientation.
Request a free individual therapy review